Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Susceptibility tensor imaging (STI) of the brain.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
Gordon Research Conference on In Vivo Magnetic Resonance
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
A monoclonal natural human IgM protects axons in the absence of remyelination.
Biogen slips as FDA extends review of MS drug
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Multiple Sclerosis Society Education Conference
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.

Pages